Mubadala Investment Co PJSC
Insider CIK 1704268 · GAIA · RXRX 10% owner · EDR · NONE · NONE 10% owner · AMD Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NONE MidCap Apollo Institutiona | P Buy | 2025-07-29 | 2025-07-31 | 773,328 | $24.16 | $18.68M | 14,561,742 | SEC↗ |
| EDR Endeavor Group Holdings, I | J Other | 2025-03-24 | 2025-03-27 | 2,232,747 | $27.50 | $61.40M | 0 | SEC↗ |
| NONE Blue Owl Technology Financ | J Other | 2025-03-24 | 2025-03-27 | 31,965,864 | — | $0 | 0 | SEC↗ |
| NONE MidCap Apollo Institutiona | P Buy | 2024-06-14 | 2025-09-11 | 1,667,108 | $25.95 | $43.26M | 13,788,414 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-03-02 | 2023-03-03 | 66,822 | $7.82 | $522.5K | 12,985,927 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-03-01 | 2023-03-02 | 48,867 | $7.94 | $388.0K | 12,919,105 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-02-28 | 2023-03-01 | 815 | $7.97 | $6.5K | 12,870,238 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-02-27 | 2023-02-28 | 52,500 | $7.69 | $403.7K | 12,869,423 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-02-24 | 2023-02-27 | 109,118 | $7.64 | $833.7K | 12,816,923 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-02-23 | 2023-02-24 | 51,864 | $7.79 | $404.0K | 12,707,805 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-02-22 | 2023-02-23 | 50,941 | $7.83 | $398.9K | 12,655,941 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-02-21 | 2023-02-22 | 94,418 | $7.74 | $730.8K | 12,605,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-02-17 | 2023-02-21 | 63,382 | $7.71 | $488.7K | 12,510,582 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-02-16 | 2023-02-17 | 42,682 | $7.90 | $337.2K | 12,447,200 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-02-14 | 2023-02-15 | 6,300 | $7.95 | $50.1K | 12,404,518 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-02-13 | 2023-02-14 | 32,474 | $7.97 | $258.8K | 12,398,218 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-02-10 | 2023-02-13 | 11,000 | $7.98 | $87.8K | 12,365,744 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-02-01 | 2023-02-02 | 600 | $7.97 | $4.8K | 12,354,744 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-01-26 | 2023-01-27 | 7,886 | $7.99 | $63.0K | 12,354,144 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-01-25 | 2023-01-26 | 24,526 | $7.88 | $193.3K | 12,346,258 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-01-10 | 2023-01-13 | 69,518 | $7.72 | $536.7K | 12,321,732 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-01-09 | 2023-01-13 | 76,046 | $7.64 | $581.0K | 12,252,214 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-01-06 | 2023-01-13 | 68,953 | $7.41 | $510.9K | 12,176,168 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-01-05 | 2023-01-13 | 80,035 | $7.38 | $590.7K | 12,107,215 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-01-04 | 2023-01-13 | 91,892 | $7.80 | $716.8K | 12,027,180 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2023-01-03 | 2023-01-13 | 141,646 | $7.50 | $1.06M | 11,935,288 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2022-12-30 | 2023-01-13 | 99,754 | $7.55 | $753.1K | 11,793,642 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2022-12-29 | 2023-01-13 | 84,622 | $7.71 | $652.4K | 11,693,888 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2022-12-28 | 2023-01-13 | 71,299 | $7.18 | $511.9K | 11,609,266 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2022-12-27 | 2023-01-13 | 145,652 | $7.24 | $1.05M | 11,537,967 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2022-12-23 | 2023-01-13 | 100,378 | $7.52 | $754.8K | 11,392,315 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-10-27 | 2022-10-31 | 2,551,020 | $9.80 | $25.00M | 11,291,937 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-20 | 3,578,653 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-20 | 2,307,475 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-20 | 5,963,140 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-20 | 745,392 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion | 2021-04-20 | 2021-04-20 | 2,738,824 | — | $0 | 6,317,477 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion | 2021-04-20 | 2021-04-20 | 3,578,653 | — | $0 | 3,578,653 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion | 2021-04-20 | 2021-04-20 | 5,963,140 | — | $0 | 8,740,917 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion | 2021-04-20 | 2021-04-20 | 745,392 | — | $0 | 7,062,869 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | P Buy | 2021-04-16 | 2021-04-20 | 2,777,777 | $18.00 | $50.00M | 2,777,777 | SEC↗ |
| GAIA GAIA, INC | J Other | 2019-05-01 | 2019-05-14 | 1,266,461 | $10.58 | $13.40M | 0 | SEC↗ |
| AMD ADVANCED MICRO DEVICES INC | X Exercise deriv | 2019-02-05 | 2019-02-07 | 75,000,000 | — | $0 | 0 | SEC↗ |
| AMD ADVANCED MICRO DEVICES INC | X Exercise | 2019-02-05 | 2019-02-07 | 75,000,000 | $5.98 | $448.50M | 75,000,000 | SEC↗ |
| AMD ADVANCED MICRO DEVICES INC | S Sale | 2019-02-05 | 2019-02-07 | 34,906,166 | $23.43 | $817.85M | 0 | SEC↗ |
| GAIA GAIA, INC | P Buy | 2018-12-04 | 2019-05-14 | 15,250 | $12.74 | $194.3K | 1,266,461 | SEC↗ |
| AMD ADVANCED MICRO DEVICES INC | S Sale | 2018-07-30 | 2018-08-01 | 22,000,000 | $19.33 | $425.26M | 109,906,166 | SEC↗ |
| AMD ADVANCED MICRO DEVICES INC | S Sale | 2017-08-04 | 2017-08-04 | 40,000,000 | $525600000.00 | $21024000.00B | 131,906,166 | SEC↗ |